A Standardized Nursing Intervention Protocol for HCT Patients

NACompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsPsychosocial Effects of Cancer and Its TreatmentTherapy-related Toxicity
Interventions
BEHAVIORAL

exercise intervention

"Those on the Standard Nursing Intervention Program will be offered six educational sessions spaced over the first 3 months after discharge.~Those on the Usual Care plus Attention Control program will be offered a copy of the complete teaching manual for Hematopoietic Cell Transplant patients which will stay with them during hospitalization and be sent home after discharge."

BEHAVIORAL

telephone-based intervention

"Those on the Standard Nursing Intervention Program will receive phone calls from the Intervention Nurse after the first 3 months and then monthly calls up to 12 months post hospital discharge.~For those on the Usual Care plus Attention Control program, the Intervention Nurse will be available by phone or email within 48 hours of request for 100 days post transplant."

DIETARY_SUPPLEMENT

dietary intervention

"Those on the Standard Nursing Intervention Program will be offered six educational sessions spaced over the first 3 months after discharge.~Those on the Usual Care plus Attention Control program will be offered a copy of the complete teaching manual for Hematopoietic Cell Transplant patients which will stay with them during hospitalization and be sent home after discharge."

OTHER

educational intervention

"Those on the Standard Nursing Intervention Program will be offered six educational sessions spaced over the first 3 months after discharge.~Those on the Usual Care plus Attention Control program will be offered a copy of the complete teaching manual for Hematopoietic Cell Transplant patients which will stay with them during hospitalization and be sent home after discharge."

OTHER

questionnaire administration

For both groups of participants, administered at baseline (prior to hospital discharge and 3, 6, and 12 months post hospital discharge.

PROCEDURE

allogeneic bone marrow transplantation

Patient with a diagnosis of a hematologic cancer scheduled for a single allogeneic bone marrow transplant.

PROCEDURE

allogeneic hematopoietic stem cell transplantation

Patient with a diagnosis of a hematologic cancer scheduled for a single allogeneic stem cell transplant.

PROCEDURE

assessment of therapy complications

Collected throughout the 12 month study period

PROCEDURE

peripheral blood stem cell transplantation

Patient with a diagnosis of a hematologic cancer scheduled for a single allogeneic stem cell transplant.

PROCEDURE

psychosocial assessment and care

Those on the Standard Nursing Intervention Program will be offered six educational sessions spaced over the first 3 months after discharge. They will also receive phone calls from the Intervention Nurse after the first 3 months and then monthly calls up to 12 months post hospital discharge.

PROCEDURE

quality-of-life assessment

For both groups of participants, questionnaires administered at baseline (prior to hospital discharge and 3, 6, and 12 months post hospital discharge.

PROCEDURE

standard follow-up care

Those on the Usual Care plus Attention Control program will be offered a copy of the complete teaching manual for Hematopoietic Cell Transplant patients which will stay with them during hospitalization and be sent home after discharge. Also the Intervention Nurse will be available by phone or email within 48 hours of request for 100 days post transplant.

Trial Locations (1)

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00951626 - A Standardized Nursing Intervention Protocol for HCT Patients | Biotech Hunter | Biotech Hunter